Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma

被引:49
作者
Kienle, P
Weitz, J
Klaes, R
Koch, M
Benner, A
Lehnert, T
Herfarth, C
Doeberitz, MV
机构
[1] Heidelberg Univ, Div Mol Diagnost & Therapy, Dept Surg, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Div Surg Oncol, Dept Surg, D-69120 Heidelberg, Germany
[3] German Canc Res Ctr, Cent Unit Biostat, D-6900 Heidelberg, Germany
关键词
D O I
10.1001/archsurg.135.2.213
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients with hepatocellular carcinoma (HCC) often develop recurrences after curative resection or liver transplantation. Therefore, tumor cell dissemination must have occurred preoperatively or intraoperatively. Current staging methods cannot reliably detect micrometastasis. Reverse transcription-polymerase chain reaction (RT-PCR) for alpha-fetoprotein (AFP) has been used to detect circulating liver cancer cells, but results in blood samples have been contradictory. Hypothesis: AFP-RT-PCR is a specific and sensitive assay for the detection of disseminated tumor cells in central venous blood and bone marrow samples of patients with HCC and has prognostic relevance. Design: Prospective consecutive series. Setting: University hospital. Patients and Methods: We performed preoperative, intraoperative, and postoperative analyses of central venous blood samples and preoperative analysis of bone marrow samples of patients with HCC and patients without malignant disease, using a modified AFP-RT-PCR method. Preoperative serum AFP levels were measured. Clinical follow-up ranged from 4 to 20 months. Main Outcome Measures: Sensitivity and specificity of AFP-RT-PCR, correlation of AFP-RT-PCR results to tumor stage and turner recurrence. Results: In serial dilution experiments, 50 AFP-expressing HepG2 cells were detected in 10 mt of blood. Peripheral blood samples of 20 healthy volunteers and bone marrow samples of 21 patients with benign diseases consistently tested negative for AFP, whereas 4 of 24 patients with HCC showed AFP expression in bone marrow samples. All these patients had advanced dis ease; however, correlation of positive RT-PCR results to tumor stage was not significant (P = .07). One of the 4 AFP-positive patients developed an intrahepatic recurrence soon after liver transplantation. Central venous blood of patients with HCC (n = 24) and patients with benign liver diseases (n = 13) equally demonstrated AFP-expressing cells. There was no correlation of RT-PCR results to serum AFP levels. Conclusions: Perioperative screening for micrometastasis in bone marrow of patients with HCC is sensitive and specific with AFP-RT-PCR and may have prognostic relevance, alpha-Fetoprotein is not a suitable marker for the detection of tumor cells in central venous blood samples.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 35 条
[1]   RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA [J].
ADACHI, E ;
MAEDA, T ;
MATSUMATA, T ;
SHIRABE, K ;
KINUKAWA, N ;
SUGIMACHI, K ;
TSUNEYOSHI, M .
GASTROENTEROLOGY, 1995, 108 (03) :768-775
[2]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[3]  
CARR BI, 1991, HEPATOLOGY, V14, pA108
[4]   ILLEGITIMATE TRANSCRIPTION - TRANSCRIPTION OF ANY GENE IN ANY CELL TYPE [J].
CHELLY, J ;
CONCORDET, JP ;
KAPLAN, JC ;
KAHN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2617-2621
[5]   ALBUMIN MESSENGER-RNA IS NOT SPECIFIC FOR CIRCULATING HEPATOMA-CELLS [J].
CHOU, HC ;
SHEU, JC ;
HUANG, GT ;
WANG, JT ;
CHEN, DS .
GASTROENTEROLOGY, 1994, 107 (02) :630-631
[6]   DETECTION OF TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER - A PROGNOSTIC FACTOR FOR DISTANT METASTASIS [J].
DIEL, IJ ;
KAUFMANN, M ;
GOERNER, R ;
COSTA, SD ;
KAUL, S ;
BASTERT, G .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) :1534-1539
[7]   CURRENT TREATMENT MODALITIES FOR HEPATOCELLULAR-CARCINOMA [J].
FARMER, DG ;
ROSOVE, MH ;
SHAKED, A ;
BUSUTTIL, RW .
ANNALS OF SURGERY, 1994, 219 (03) :236-247
[8]   Hematogenous spreading of hepatocellular carcinoma cells: Possible participation in recurrence in the liver [J].
Funaki, NO ;
Tanaka, J ;
Seto, SI ;
Kasamatsu, T ;
Kaido, T ;
Imamura, M .
HEPATOLOGY, 1997, 25 (03) :564-568
[9]   SPECIFIC DETECTION OF CARCINOEMBRYONIC ANTIGEN-EXPRESSING TUMOR-CELLS IN BONE-MARROW ASPIRATES BY POLYMERASE CHAIN-REACTION [J].
GERHARD, M ;
JUHL, H ;
KALTHOFF, H ;
SCHREIBER, HW ;
WAGENER, C ;
NEUMAIER, M .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :725-729
[10]  
Ghossein RA, 1996, CANCER-AM CANCER SOC, V78, P10, DOI 10.1002/(SICI)1097-0142(19960701)78:1<10::AID-CNCR3>3.3.CO